. British Council Harvard Kennedy School IRSA Inversiones y Representaciones SA Airbus SAS Vestas Wind Systems A/S Evonik Industries AG Metabolix Novartis AG JPMorgan Chase & Co. DISH Network Empresa Periodistica El Mercurio SAP Intel Corporation Yale University Trade Union Advisory Committee to the

15.000 -19,719.35 Nov 28 Transfer NIPPON TELEG & TEL CORP SPON ADR TO Y I 36508 4200 CUSIP: 654624105 -2.210.000 -90,123.80 Nov28 Transfer NOVARTIS AG SPON ADR TO Y1 36508 4200 CUSIP. 66987V109 -975.000 -67,353.00 Nov28 Tramt« P.T. TELEKOMUNIKASI INDONESIA SPON ADR TO VI 36508 4200 CUSIP. 71

c. LexisNexis Group Linkedln Corp. Major Lindsey & Africa LLC Miami Herald Media Co. Morgan Stanley Mylan NV NASDAQ Inc. NatWest Markets PLC Novartis AG Oath Inc. Paramount Group Inc. Partnership for New York City Pennsylvania Bar Association Pfizer Inc. RELX PLC Regions Financial Corp. Royal Du

Civil Liberties Alliance New Jersey State Bar Association New York State Bar Association New York University Nike Inc. Northeastern University Novartis AG PG&E Corp. Parker Drilling Company Pennsylvania Bar Association Pfizer Inc. Pogue Construction ITC To Probe Economic Effect Of Renewable Energy

C Microsoft Corp. Mitsubishi Motors Corp. National Association for the Advancement of Colored People New York University Nissan Motor Co. Ltd. Novartis AG PNC Financial Services Group Inc. Temple University The Madison Square Garden Co. Trelleborg AB Wal-Mart Stores Inc. Walgreens Co. Yale Univer

iation Lehman Brothers Holdings Inc. LexisNexis Group Linkedln Corp. Morgan Stanley NantKwest Inc. Netflix Inc. New York City Bar Association Novartis AG Outokumpu PricewaterhouseCoopers International Ltd. Questcor Pharmaceuticals, Inc. RELX PLC Spartan Race Inc. Thomson Reuters Corp. EFTA00032

ville Corp. LM Ericsson Telephone Company Ligand Pharmaceuticals Inc. Microsoft Corporation NFL Enterprises LLC National Basketball Association Novartis AG Papa John's International Inc. Petrobras Plantronics Inc. R.J. Reynolds Tobacco Co. Inc. RD Legal Funding LLC Skechers USA Inc. StreetEasy Inc

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

tor and Presenter Founder and Chief Executive Officer Harvard Kennedy School Airbus SAS Vestas Wind Systems A/S Evonik Industries AG Metabolix Novartis AG JPMorgan Chase & Co. DISH Network USA France Denmark Germany USA Switzerland USA USA Empresa Periodistica El Chile Mercurio SAP Intel C

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

eller & Co. World Vision International Banco BTG Pactual The Financial Times Barclays UNI Global Union University of Miami Xinhua News Agency Novartis AG Bunge Limited Germany France Saudi Arabia USA United Kingdom Switzerland USA USA United Arab Emirates Mexico Saudi Arabia Switzerland U

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te